Showing results (821-830 of 1,201) with videos related to
Sort By:
Pageof 121
Optics Letters|August 30, 2019
Efficient nonlinear compression of a mode-locked thin-disk oscillator to 27 fs at 98 W average powerChia-Lun Tsai, Frank Meyer, Alan Omar, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|October 17, 2018
A biopsychosocial model of resilience for breast cancer: A preliminary study in mainland ChinaZeng Jie Ye, Chao Hua Peng, Hao Wei Zhang, et al.Cancer Biotherapy & Radiopharmaceuticals|December 20, 2015
Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular CarcinomaHong-Yuan Liang, Qi-Yong Guo, Wei Sun, et al.BMC Nephrology|July 1, 2020
Potential value of three-dimensional ultrasonography in diagnosis of diabetic nephropathy in Chinese diabetic population with kidney injuryNan Li, Yi-Ru Wang, Xiao-Qi Tian, et al.Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|December 25, 2025
Regulation of soil amendments on soil physical structure and microbial community in albic layer of albic soilWang Ling-Li, Shi Yuan-Liang, Shi Hao-Xin, et al.Ecotoxicology and Environmental Safety|December 31, 2020
The negative role of histone acetylation in cobalt chloride-induced neurodegenerative damages in SHSY5Y cellsZhenkun Guo, Jianping Tang, Junxiang Wang, et al.Health and Quality of Life Outcomes|December 10, 2020
Minimum clinical important difference for resilience scale specific to cancer: a prospective analysisZeng Jie Ye, Zhang Zhang, Ying Tang, et al.Frontiers in Psychiatry|March 6, 2023
Measuring resilience by cognitive diagnosis models and its prediction of 6-month quality of life in Be Resilient to Breast Cancer (BRBC)Mu Zi Liang, Peng Chen, M Tish Knobf, et al.BMC Cancer|October 30, 2024
VASN promotes the aggressive phenotype in ARID1A-deficient lung adenocarcinomaDan-Ni Wu, Kang-Liang Zhang, Rui-Heng Chen, et al.Cancer Science|November 26, 2021
Mechanism of sensitivity to cisplatin, docetaxel, and 5-fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpressionTong-Chao Zhao, Zhi-Hang Zhou, Wu-Tong Ju, et al.Pageof 121